logo

For the Inventor, By the Inventor

Vincennes, France

Jean-Dominique Bourzat

This inventor holds 51 USPTO granted patents, primarily in Taxoid Chemistry (CPC class 5495). Top assignees: Rhone-Poulenc Rorer S.a., Aventis Pharma S.a., Rhone-Poulenc Sante. Active years: 1980-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Dominique Bourzat. Retrieved from https://idiyas.com/inventor/jean-dominique-bourzat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 51

% Patents Active = 96.1

Average Co-Inventor Count = 3.5

ph-index = 12

Forward Citations = 489(Granted Patents)

Forward Citations (Not Self Cited) = 471(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Paris, FR (1980 - 1992)
  • Vitry, FR (2003)
  • Vincennes, FR (1991 - 2006)

Company Filing History:

goldMedal29 out of 247 
 
Rhone-Poulenc Rorer S.a.
 patents
silverMedal8 out of 377 
 
Aventis Pharma S.a.
 patents
bronzeMedal5 out of 192 
 
Rhone-Poulenc Sante
 patents
4. 3 out of 521 
 
Rhone-Poulenc Industries
 patents
5. 1 out of 39 
 
Aventis Pharma Limited
 patents
6. 1 out of 1 
 
Phone-Poulenc Sante
 patent
7. 1 out of 142 
 
Rhone-Poulenc S.a.
 patents
8. 3 out of 834,513 
Other
 patents

Years Active: 1980-2006

Loading Chart...
Areas of Expertise:
Taxoids
Pharmaceutical Compositions
Cell Adhesion
Farnesyl Transferase Inhibitors
Oxazolidinecarboxylic Acid
Dihydro-benzo(1,4)oxazines
Aza-bicycles
Baccatin III Derivatives
Pathological Conditions
Multidrug Resistance
Taxane Derivatives
N-phenylglycinamide
51 patents (USPTO):Explore Patents
1. 7074821 - Taxoids, their preparation and pharmaceutical composition containing them (2006-07-11),
2. 6632814 - Dihydro-benzo(1,4)oxazines (2003-10-14),
3. 6608084 - Aza-bicycles which modulate the inhibition of cell adhesion (2003-08-19),
4. 6593482 - Methods for preparing new taxoids and pharmaceutical compositions containing them (2003-07-15),
5. 6548533 - Ureido substituted pyrrolidines (2003-04-15),
6. 6444825 - Process for the preparation of an oxazolidinecarboxylic acid which is useful for preparing therapeutically active taxoids (2002-09-03),
7. 6387946 - Methods for treating pathological conditions of abnormal cell proliferation (2002-05-14),
8. 6384071 - Taxoids, their preparation and pharmaceutical compositions containing them (2002-05-07),
9. 6372780 - Methods of treating cell lines expressing multidrug resistance P-glycoprotein (2002-04-16),
10. 6331635 - Taxoids, their preparation and pharmaceutical compositions containing them (2001-12-18),
11. 6232477 - Methods of preparing new taxoids and pharmaceutical compositions containing them (2001-05-15),
12. 6218406 - Farnesyl transferase inhibitors, their preparation, the pharmaceutical compositions which contain them and their use in the preparation of medicaments (2001-04-17),
13. 6194582 - Taxoids, their preparation and pharmaceutical compositions containing them (2001-02-27),
14. 6160135 - Taxoids, preparation thereof and pharmaceutical compositions containing (2000-12-12),
15. 6124465 - Farnesyl transferase inhibitors, their preparation, the pharmaceutical (2000-09-26),

Title: The Innovative Contributions of Jean-Dominique Bourzat

Introduction: Jean-Dominique Bourzat, located in Vincennes, France, is a distinguished inventor with a prolific record of 51 patents. His work primarily focuses on the development of pharmaceutical compositions, particularly in the area of antitumor activity.

Latest Patents: Among his latest patents are the advancements in taxoids, specifically titled "Taxoids, their preparation and pharmaceutical composition containing them." These new taxoids, represented by general formula (I), offer remarkable antitumor activity, showcasing the potential they hold for cancer treatment. Additionally, he has contributed to the field with patents related to dihydro-benzo(1,4)oxazines.

Career Highlights: Throughout his career, Jean-Dominique has made significant strides working with esteemed companies such as Rhône-Poulenc Rorer S.A. and Aventis Pharma S.A. His innovative efforts in the pharmaceutical industry have undoubtedly propelled advancements in medicinal chemistry and drug formulation.

Collaborations: Jean-Dominique has had the opportunity to collaborate with notable colleagues, including Alain Commercon and Alain Commercedillaon. These partnerships have fostered an environment of innovation and creativity, allowing for the exchange of ideas and expertise in the realm of pharmaceutical research.

Conclusion: In summary, Jean-Dominique Bourzat's contributions to the field of pharmaceuticals through his numerous patents and collaborations illustrate his commitment to innovation and improving healthcare outcomes. His impactful work continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…